Objectives/Hypothesis: Exposure of laryngeal epithelia to pepsin during extra-esophageal reflux causes depletion of laryngeal protective proteins, carbonic anhydrase isoenzyme III (CAIII), and squamous epithelial stress protein Sep70. The first objective of this study was to determine whether pepsin has to be enzymatically active to deplete these proteins. The second objective was to investigate the effect of pH on the activity and stability of human pepsin 3b under conditions that might be found in the human esophagus and larynx.
INTRODUCTION
Laryngopharyngeal reflux (LPR), defined as the backflow of gastric contents into the laryngopharynx, contributes to several otolaryngologic inflammatory disorders and neoplastic diseases. 1, 2 It is has been reported in up to 10% of patients referred to otolaryngologists for treatment and in 50% of patients with laryngeal and voice disorders. 1 Damage to the laryngeal epithelium is believed central in the development of reflux-attributed laryngeal disease, thought to occur after a breakdown in defense. Despite recent advances in diagnosing LPR, very little is known regarding its effect on the biology and biochemistry of the laryngeal epithelium.
For several years, a presumed relationship between LPR and laryngeal lesions and disease contributed to a focus on reflux pH as the principal diagnostic and therapeutic target for LPR. Double-probe pH monitoring is commonly used to diagnose acid reflux into the laryngopharynx; however, this does not address the role of non/ weak acid reflux, which is now known to occur, causing symptoms and mucosal injury. [3] [4] [5] [6] Proton pump inhibitors (PPIs), the most potent form of acid suppression therapy available, are widely prescribed to treat LPR, yet even high doses can often be inadequate to treat many patients with LPR-attributed symptoms and disease. 3, 7 This is because PPI therapy decreases the hydrogen ion concentration of the refluxed fluid but not the number or duration of reflux events. 3 With new evidence that symptoms and injury can be caused by non/weak acid reflux (using combined multichannel intraluminal impedance pH), it is clear that PPI therapy alone has limited ability to protect patients from LPR-induced damage.
It is likely that patients with incomplete response to acid suppression may have significant involvement from other components of the gastric refluxate, such as pepsin and bile acids, both of which can injure the laryngeal/ esophageal epithelium at non/weakly acidic pH. Pepsin is the major proteolytic enzyme produced in the stomach by gastric chief cells. We have demonstrated that pepsin is present in the laryngeal epithelium of patients with reflux-attributed laryngeal disease but is absent in normal control subjects. 8 Furthermore, we have determined a significant association between the presence of pepsin in laryngeal epithelia of LPR patients and the depletion of two laryngeal protective proteins, carbonic anhydrase isoenzyme III (CAIII) and squamous epithelial stress protein Sep70. 8 -10 Using an established porcine in vitro model, we have demonstrated that exposure of laryngeal mucosa to pepsin, although not to low pH alone, causes depletion of CAIII and Sep70 protein levels. These findings suggest that the pepsin present in laryngeal epithelia of LPR patients is likely to be the causal factor for the observed depletion of CAIII and Sep70 proteins.
The objectives of this study were to 1) determine whether enzymatically active pepsin is required to deplete laryngeal CAIII and Sep70 protective proteins and 2) establish whether pepsin, present in the laryngeal epithelium of LPR patients (which is presumably inactive because the mean pH of the laryngopharynx is pH 6.8, and pepsin is maximally active at pH 2.0 and inactive at pH Ն6.5), is stable and thus could be reactivated after a decrease in pH, as would occur by a subsequent acidic reflux event. To accomplish these objectives, the affect of exposure of laryngeal mucosa to active/inactive pepsin (porcine pepsin A, 1 mg/mL, Ϯ pepstatin, 23 g/mL) on CAIII and Sep70 protein levels was investigated using the established porcine in vitro model. 9 The effect of pH on activity and stability of human pepsin 3b was measured by kinetic assay by measuring the rate of hydrolysis of a specific synthetic substrate for human pepsin 3b. Hydrolysis of the peptide substrate was measured at pH 1.5 to pH 8.0 to determine peptic activity at each pH. The stability of pepsin was measured by incubating the enzyme at pH 2.0 to pH 8.0 for 24 hours at 37°C, after which the rate of hydrolysis of the substrate was measured at pH 3.0.
METHODS

Isolation of Pepsin 3b
Human gastric juice was collected from patients attending the laryngology outpatient clinic at Froedtert Hospital, Milwaukee, WI, scheduled to have a transnasal esophagoscopy for clinical indications. Approximately 5 to 10 mL of gastric juice was aspirated from patients at the end of their scheduled procedure. Gastric juice samples were pooled and pepsin 3b isolated by anion exchange chromatography. This study was approved by the Institutional Review Board at the Medical College of Wisconsin, study number PRO 00004759, and informed consent was obtained from all participants.
Gastric juice was initially filtered through a piece of 113 V, 320-mm diameter Whatman filter paper (Fisher Scientific, Pittsburgh, PA) to remove mucoid and particulate matter. The filtrate was then dialyzed against 50 mmol/L sodium acetate buffer, pH 4.1 at 4°C. Partial purification of pepsins was performed using a diethyl amino ethyl cellulose column (DE52, 2.5 ϫ 10 cm, Whatman, Inc., NJ) equilibrated with dialysis buffer at 4°C. Negatively charged proteins, including pepsin 3b, were eluted from the DE52 column with salt (sodium acetate/1 mol/L NaCl at 2 mL/min). Fractions containing protein (determined by measuring optical density at 280 nm) were pooled and dialyzed against 50 mmol/L sodium acetate at 4°C to remove all salt before performing the second high-resolution anion exchange chromatography with a Pharmacia Mono Q, 0.5 ϫ 5 cm, column (GE Health Care, Piscataway, NJ) developed with a linear gradient of 0.09 to 1.0 mol/L NaCl in 50 mmol/L sodium acetate, pH 4.1, over 30 minutes at 0.75 mL/minute. Pepsin 3b was identified by chromatography pattern, isolated, and stored at -20°C in 50% glycerol. 11
Synthetic Peptide Substrate for Pepsin
The synthetic peptide substrate for pepsin (Lys-Pro-AlaGlu-Phe-PNP-Arg-Leu-COOH, molecular weight ϭ 1,052.18; PNP ϭ paranitrophenylalanine) was synthesized in the Protein Analysis Core Laboratory at Wake Forest University Health Sciences, Winston-Salem, NC. This peptide is cleaved specifically by pepsin between Phe-5 and PNP-6. Cleavage was monitored by decreasing absorbance at 300 nm. 12 
Porcine In Vitro Model
Porcine laryngeal mucosa was exposed to pepsin (porcine pepsin A, 1 mg/mL) Ϯ pepstatin (23 g/mL, an irreversible inhibitor of pepsin) using an established in vitro organ culture model. 9 The activity of pepsin Ϯ pepstatin was measured by kinetic assay (rate of hydrolysis of the synthetic peptide substrate) 12 before it was applied to the porcine laryngeal mucosa.
Kinetic Assays
The rate of hydrolysis of the synthetic peptide substrate (70 mol/L) by pepsin (0.1 g/mL) at pH 1.5 to 8.0 was measured by kinetic assay at 300 nm. Pepsin was prepared in sodium acetate, 0.2 mol/L, pH 4.1. HCl was added to obtain each pH, taking note of the amount added and of what concentration so that the final [Cl Ϫ ] could be balanced using 1 mol/L NaCl. The rate of the first 10% hydrolysis was calculated for each reaction and a graph of the mean (ϮSEM) rate (nmol/L per min, n ϭ 2) for each pH plotted.
To investigate the stability of human pepsin 3b, pepsin was prepared in sodium acetate buffer (0.2 mol/L) with the pH adjusted to pH 2.0 to 8.0 and [Cl Ϫ ] balanced with NaCl. After incubation at 37°C for 24 hours, the rate of hydrolysis of the peptide substrate (70 mol/L, prepared in sodium formate, 0.1 mol/L, pH 3.0) was measured by the decrease in absorbance at 300 nm at pH 3.0. The mean (ϮSEM) rate (nmol/L per min, n ϭ 3) after incubation at 37°C for 24 hours at each pH was compared with the mean (ϮSEM) rate (nmol/L per min, n ϭ 2) at each pH without incubation for 24 hours at 37°C.
The pH was measured before and after the 24-hour incubation at 37°C. It did not change.
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis and Western Blot Analysis
Porcine laryngeal specimens were homogenized and lysed as described by Axford et al. 13 Ten micrograms of total protein was separated on either a 10% or 12% sodium dodecyl sulfatepolyacrylamide gel by electrophoresis, transferred to a nitrocellulose membrane (Amersham International, Little Chalfont, UK), and probed with either a mouse monoclonal antihuman CAIII diluted 1:1,500 (Nanogen, Toronto, Canada) or a mouse monoclonal to antihuman Sep70 diluted 1:8,000 (Moravian Biotechnology, Bruno, Czech Republic). All Western blots were stripped using a Re-Blot Plus strong antibody stripping solution (Chemicon International, Temecula, CA), and nonspecific sites were blocked using nonfat milk and reprobed for actin using the monoclonal antiactin diluted 1:10,000 (Oncogene Research Products, San Diego, CA). This was performed to ensure equal loading of total protein in all lanes. All antibodies were diluted in phosphate-buffered saline containing 1% (vol/vol) Tween-20. Detection was by enhanced chemiluminescence. The specificity and sensitivity of the antihuman CAIII and Sep70 antibodies have previously been described. 13, 14 
RESULTS
Western blot analysis revealed that exposure of laryngeal mucosa to active, but not inactive, pepsin results in the depletion of laryngeal CAIII and Sep70 protein levels (Fig. 1) . Human pepsin 3b has maximum activity at pH 2.0 and remains active until pH 6.5 (Fig. 2) . Although pepsin is inactive at pH 6.5 and above, it remains stable and can be reactivated after a decrease in pH (Fig. 3) . We have demonstrated that human pepsin 3b can be incubated at pH 7.0 for up to 24 hours at 37°C and then be reactivated when the pH is reduced to 3.0 to obtain 79 Ϯ 11% of its original activity. Pepsin retains 70% to 80% of its original activity whether it is incubated at pH 7.0 for 5 minutes or 24 hours at 37°C. Pepsin is not irreversibly inactivated until pH 8.0.
DISCUSSION
We have demonstrated that exposure of laryngeal mucosa to active, but not inactive, pepsin results in the depletion of laryngeal CAIII and Sep70 protective proteins. Thus, patients with reflux-attributed laryngeal disease, who have depleted levels of these proteins, must have been exposed to active pepsin.
In 1965, Piper and Fenton 15 demonstrated peptic activity in gastric juice using proteolysis of radioiodinated serum albumin at pH 2.0 as a measure of pepsin activity. They reported maximal activity at pH 2.0 and demonstrated that pepsin was inactive at pH 6.5. The authors also reported the stability of pepsin by incubating gastric juice at 37°C for 10 minutes at varying pH levels before titrating to pH 2.0. Of interest, although pepsin is inactive Fig. 3 . Stability of human pepsin 3b. Pepsin was incubated at indicated pH (2.0 -8.0) for 24 hours at 37°C, after which rate of hydrolysis of peptide substrate (70 mol/L) was measured at pH 3.0. Although pepsin (0.1 g/mL) is inactive at neutral pH, it is stable. After incubation at pH 7.0 for 24 hours, pepsin can be reactivated by decreasing the pH to 3.0, retaining 79% Ϯ 11% of its original activity (n ϭ 3). Fig. 1 . Effect of active/inactive pepsin on laryngeal Sep70 and CAIII protein levels. We have previously shown that laryngeal Sep70 protein levels are depleted after exposure to pepsin (porcine pepsin A, 1 mg/mL) at pH 4.0 for 3 hours. 10 When pepsin is inactivated with pepstatin (23 g/mL), this reduction in Sep70 levels is not observed. We have also shown a decrease in laryngeal CAIII protein levels after exposure to pepsin at pH 4.0 for 20 minutes (followed by 4 hr incubation in media at pH 7.4). 9 In presence of pepstatin, CAIII is not depleted. Thus, active, and not inactive, pepsin causes depletion in laryngeal Sep70 and CAIII protein levels. Blots were stripped and reprobed for actin to show equal loading of total protein. CAIIIrp ϭ carbonic anhydrase isoenzyme III recombinant protein (positive control); LB ϭ loading buffer. Fig. 2 . Effect of pH on activity of human pepsin 3b. Rate of hydrolysis of pepsin-specific peptide substrate (70 mol/L) by human pepsin 3b (0.1 g/mL) at pH 1.5 to 8.0 was measured by kinetic assay at 300 nm. Pepsin has maximum activity at pH 2.0 and is inactive at pH 6.5 (n ϭ 2).
at pH 6.5, it was shown to be stable at this pH because it could be reactivated when the pH was dropped to pH 2.0, retaining 70% of its original activity.
We repeated this study using pepsin 3b isolated from human gastric juice and a pepsin-specific peptide substrate. In addition, we investigated whether pepsin would remain stable for a longer time period. Piper and Fenton incubated pepsin at various pHs for 10 minutes at 37°C, after which they decreased the pH to 2.0 and measured peptic activity. In this study, we incubated pepsin at pH 2.0 to 8.0 for 24 hours at 37°C and then decreased the pH to 3.0 and measured peptic activity. Our data are consistent with that of Piper and Fenton and further reveal that pepsin remains stable at pH 7.0 for at least 24 hours at 37°C, retaining 79% Ϯ 11% of its original activity on re-acidification. Thus, as long as pepsin remains below pH 8.0, it remains stable and thus has the potential to be reactivated if the pH significantly decreases again. This is of clinical importance because pepsin, which can be detected in laryngeal epithelia after a reflux event, 8, 10 could be inactive because the mean pH of the laryngopharynx is 6.8. However, even if pepsin present in the laryngeal tissue is enzymatically inactive, it would potentially remain stable and thus could be reactivated after a subsequent acidic reflux event or once taken up by laryngeal epithelial cells into acidic intracellular compartments. Recent electron microscopy studies demonstrating colocalization of pepsin with specific markers for the receptor mediated endocytic pathway (transferrin and clathrin) have confirmed our initial confocal microscopy findings that pepsin is taken up by laryngeal epithelial cells by a specific process that appears to be receptor mediated (unpublished data). 10 Thus, pepsin would be expected to be found in intracellular compartments such as the transreticular Golgi or lysosomes, which are approximately pH 5 and 4, respectively. Ongoing studies in the lead author's research laboratory will further delineate the uptake of pepsin by laryngeal epithelial cells and its intracellular path.
CONCLUSION
Pepsin can be detected in laryngeal epithelia after a reflux event. The results of this study show that pepsin that remains in the laryngopharynx after a reflux event is reversibly inactivated because the mean pH of the laryngopharynx is 6.8, a pH at which the enzymatic activity of pepsin is undetectable. Significantly, these data show that pepsin may remain in a state that can be reversibly reactivated until the pH of the environment increases above pH 8.0. Thus, pepsin could remain stable in the larynx and be reactivated at a later time after a decrease in pH, such as could be caused by a subsequent acidic reflux event.
Pepsin could also potentially be reactivated after uptake by the laryngeal epithelial cells into intracellular compartments of lower pH such as the transreticular Golgi network or lysosomes.
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